KAICO Ltd.

KAICO Ltd.

Private
JapanHealthcare & Life Scienceshttps://www.kaicoltd.jp/en/

Last Round

Series B

Apr 15, 2025

Total Funding Raised

$10.72M

Company Overview

KAICO Ltd. is a biotechnology startup spun out of Kyushu University that specializes in developing and manufacturing proteins, vaccines, and diagnostics using a proprietary silkworm-based production platform. The company's core technology, the silkworm-baculovirus expression system, enables the efficient production of complex proteins that are difficult to express using conventional methods. KAICO's business includes contract protein expression services, the sale of reagents, and the development of oral vaccines and feed additives for both veterinary and human applications. A key product is an oral vaccine and feed additive for pigs, with plans to expand into human vaccines to address future pandemics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain, D2C Brands

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

recombinant protein productionsilkworm-baculovirus expression systemdifficult-to-express proteinssilkworm bioreactorscustom protein expressionvaccine developmentcontract development and manufacturing organizationCDMOcontract research organizationCRObiomanufacturingcustom-made reagentsdrug discoverydiagnostic agentsinsect cell expressionanimal healthfeed additives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KAICO Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

KAICO Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BApr 15, 2025
Series A ExtensionJan 19, 2024
Series A ExtensionDec 15, 2021
Series AMay 22, 2020
SeedOct 26, 2018

Key People

Founding team and executive leadership

Masahiro Taniguchi

Director, Chief Technology Officer(CTO)

Executive Team

KAICO Ltd. Investors

Notable investors and investment history

InvestorRounds
株式会社FFGベンチャービジネスパートナーズSeries A Extension, Series A, Seed
ITOCHU Technology VenturesSeries A Extension, Series B
Japan Science and Technology AgencySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2026

    Partnered with Reber Genetics to distribute KAICO Powder in Taiwan.

  • Nov 11, 2025

    Will exhibit at the 11th Asia Pig Veterinary Society Congress in November 2025.

KAICO Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KAICO Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KAICO Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJapan
Employee Range11
Year Founded2018
Last FundingApr 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.